At Home With Art
Novartis India’s Ranjit Shahani’s enviable collection reflects his journey from a novice to an expert in contemporary art
Krishna Gopalan - August 19, 2017
Managing Growth 2017- Part 2
Will demonetisation hurt? Can the Budget spur a growth recovery? Here's what four CEOs predicted for the next fiscal
March 17, 2017
Managing Growth 2017- Part 1
CEOs from diverse sectors on what's in store for 2017
March 17, 2017
Will Sun rise again?
Can Sun Pharma’s Dilip Shanghvi work his merger magic on Ranbaxy?
Kripa Mahalingam - June 15, 2015
Critical condition
Drug majors are shifting clinical trials out of India as lawmakers turn on the heat
Kripa Mahalingam - June 17, 2015